본문바로가기
Q
U
I
C
K

Business

SK bioscience’s effort reaches beyond development and manufacture of premium vaccines
and extends to working with domestic and overseas partners to create a healthy future for mankind.

Business Overview

SK bioscience has established a broad product portfolio and continues to invest in vaccine research,
which will be the driving force in the life science business in the future.
SK bioscience will develop premium vaccines based on superb technology and contribute promoting public health and contribute to the promotion of public health.
Speed of Execution with Quality
SKYVAX Program

SK bioscience's proprietary product supply to
developing countries including LMIC

Platform Technology
  • - Contractual development & manufacturing service
  • - Technology transfer to local manufacture including
Manufacturing Versatility

Out-licensing and co-development
for US and Europe market for next decade

Market Leading Sales
/ Marketing Infrastructure
  • Joint sales and consignment production
    based on leading position
    in domestic vaccine market
Share Innovation

Business field

Process development
R&D center
  • Various platform technologies for diverse vaccine types
  • Process development team
  • Evaluation/analysis team
  • Bacterial vaccine team
  • Viral vaccine team
  • New project team
Development & commercial manufacturing
L HOUSE
  • Pioneer in successful adaptation of ‘single-use system’ for vaccines on commercial scale
  • ‘Multi-modular system’ for diverse vaccine types
  • Flexibility using single-use System

  • Diverse platforms

  • Future expansion

Professional sales/marketing
Professional
  • Specialized sales/marketing infrastructure make the company as a leader in the domestic vaccine market
  • Various consignment production systems improve the convenience of vaccination
  • Unified system from licensing to selling

  • Specialized strategies for public/private market

  • Portfolio for all ages,
    from infants to elderly